Biotika a.s. (BSSE:1BSL01AE)
9.00
0.00 (0.00%)
At close: Aug 6, 2025
Biotika a.s. Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Operating Revenue | 12.04 | 16.18 | 11.03 | 8.91 | 17.65 | 19.93 | Upgrade
|
Other Revenue | -0.55 | - | - | - | - | 6.4 | Upgrade
|
Revenue | 11.5 | 16.18 | 11.03 | 8.91 | 17.65 | 26.33 | Upgrade
|
Revenue Growth (YoY) | -27.71% | 46.70% | 23.83% | -49.53% | -32.98% | -11.89% | Upgrade
|
Cost of Revenue | 12.27 | 15.47 | 8.52 | 16.09 | 17.1 | 24.39 | Upgrade
|
Gross Profit | -0.77 | 0.71 | 2.51 | -7.19 | 0.55 | 1.94 | Upgrade
|
Selling, General & Admin | 6.06 | 5.65 | 4.78 | 0.02 | 0.02 | - | Upgrade
|
Other Operating Expenses | -6.58 | -6.6 | -2.76 | -7.67 | -1.63 | - | Upgrade
|
Operating Expenses | 0.99 | 0.54 | 3.54 | -7.66 | -1.61 | - | Upgrade
|
Operating Income | -1.76 | 0.17 | -1.04 | 0.47 | 2.16 | 1.94 | Upgrade
|
Interest Expense | - | - | -0 | - | - | - | Upgrade
|
Interest & Investment Income | 0.08 | 0.08 | 0.26 | 0.04 | 0.57 | 0.56 | Upgrade
|
Currency Exchange Gain (Loss) | 0 | -0.01 | -0.02 | - | - | - | Upgrade
|
Other Non Operating Income (Expenses) | -0 | -0 | -0.01 | - | - | - | Upgrade
|
EBT Excluding Unusual Items | -1.68 | 0.23 | -0.8 | 0.51 | 2.73 | 2.5 | Upgrade
|
Gain (Loss) on Sale of Investments | 0.43 | - | - | - | - | - | Upgrade
|
Gain (Loss) on Sale of Assets | -0.13 | - | - | - | - | - | Upgrade
|
Asset Writedown | -0.01 | -0.01 | -0.04 | - | - | - | Upgrade
|
Pretax Income | -1.39 | 0.22 | -0.84 | 0.51 | 2.73 | 2.5 | Upgrade
|
Income Tax Expense | -0.14 | -0.15 | -0.02 | 0.11 | 0.45 | 0.48 | Upgrade
|
Net Income | -1.25 | 0.37 | -0.82 | 0.41 | 2.28 | 2.02 | Upgrade
|
Net Income to Common | -1.25 | 0.37 | -0.82 | 0.41 | 2.28 | 2.02 | Upgrade
|
Net Income Growth | - | - | - | -82.17% | 12.55% | 79.30% | Upgrade
|
Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | - | - | Upgrade
|
Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | - | - | Upgrade
|
EPS (Basic) | -1.79 | 0.53 | -1.17 | 0.58 | - | - | Upgrade
|
EPS (Diluted) | -1.79 | 0.53 | -1.17 | 0.58 | - | - | Upgrade
|
Free Cash Flow | -1.75 | 0.65 | -0.08 | 0.04 | 3.17 | - | Upgrade
|
Free Cash Flow Per Share | -2.50 | 0.93 | -0.12 | 0.06 | - | - | Upgrade
|
Dividend Per Share | - | - | - | 0.500 | 2.600 | 2.300 | Upgrade
|
Dividend Growth | - | - | - | -80.77% | 13.04% | 31.43% | Upgrade
|
Gross Margin | -6.72% | 4.37% | 22.73% | -80.67% | 3.09% | 7.38% | Upgrade
|
Operating Margin | -15.29% | 1.04% | -9.40% | 5.29% | 12.23% | 7.38% | Upgrade
|
Profit Margin | -10.87% | 2.28% | -7.43% | 4.55% | 12.90% | 7.68% | Upgrade
|
Free Cash Flow Margin | -15.22% | 4.02% | -0.73% | 0.44% | 17.97% | - | Upgrade
|
EBITDA | -0.44 | 1.48 | 0.28 | 1.86 | 4.28 | 4.07 | Upgrade
|
EBITDA Margin | -3.80% | 9.12% | 2.50% | 20.87% | 24.24% | 15.47% | Upgrade
|
D&A For EBITDA | 1.32 | 1.31 | 1.31 | 1.39 | 2.12 | 2.13 | Upgrade
|
EBIT | -1.76 | 0.17 | -1.04 | 0.47 | 2.16 | 1.94 | Upgrade
|
EBIT Margin | -15.29% | 1.04% | -9.40% | 5.29% | 12.23% | 7.38% | Upgrade
|
Effective Tax Rate | - | - | - | 21.17% | 16.58% | 19.05% | Upgrade
|
Revenue as Reported | 19.54 | 23.28 | 14.29 | 16.58 | 19.28 | 26.33 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.